June 21, 2024
University of Cincinnati laryngology researchers are using high-speed camera technology to learn more about the physiology of voice and swallowing and improve patient outcomes.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
January 11, 2024
WVXU highlighted a new trial at the University of Cincinnati that will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
November 16, 2018
Three University of Cincinnati (UC) faculty members spoke at the 10th Symposium on Biodegradable Metals for Biomedical Applications, held at Oxford University, Oxford England, from August 26-31, 2018.
March 17, 2021
Charles Prestigiacomo, MD, created the Advanced Anatomy of the Head and Neck elective, offered to fourth-year students at the UC College of Medicine who are getting ready to match in surgical residencies and begin performing procedures on patients. He and colleagues are seeing how this class is better preparing students to begin their careers with a little more “real-life” practice.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.